Preceyes, a spin-off of TU/e, has entered into a collaboration with Nightstar (UK) for the development of a high-precision drug delivery technology in the eye. Also an agreement has been signed with Oxford University to perform clinical studies with the eye surgery robot.
Nightstar will use the Preceyes robotic device to further refine the delivery of gene therapy to the subretinal space for a range of inherited retinal diseases.
In the course of the collaboration, Nightstar will purchase the Preceyes Surgical System for use in human gene therapy trials.
Preceyes’ high-precision robotic system targets ocular surgery, with vitreoretinal surgical procedures as the initial target market. The technology promises to improve the delivery of existing ocular surgery as well as enables the development of new treatments such as high-precision drug delivery, assisting eye surgeons in performing the most demanding surgical tasks.
For an animation video of the system click here.
Editing for Eindhoven News: Chuan